Nuvation Bio (NUVB)
(Delayed Data from NYSE)
$2.41 USD
+0.07 (2.99%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $2.41 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth D Momentum F VGM
Nuvation Bio Inc. (NUVB) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$6.75 | $10.00 | $5.00 | 188.46% |
Price Target
Based on short-term price targets offered by four analysts, the average price target for Nuvation Bio Inc. comes to $6.75. The forecasts range from a low of $5.00 to a high of $10.00. The average price target represents an increase of 188.46% from the last closing price of $2.34.
Analyst Price Targets (4 )
Broker Rating
Nuvation Bio Inc. currently has an average brokerage recommendation (ABR) of 1.20 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by five brokerage firms. The current ABR compares to an ABR of 1.17 a month ago based on six recommendations.
Of the five recommendations deriving the current ABR, four are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 80% and 20% of all recommendations. A month ago, Strong Buy made up 83.33%, while Buy represented 16.67%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 4 | 4 | 5 | 5 | 5 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.20 | 1.20 | 1.17 | 1.17 | 1.17 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/6/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
8/5/2024 | Wedbush Securities | David M Nierengarten | Strong Buy | Strong Buy |
7/17/2024 | H.C. Wainwright & Co. | Robert Burns | Strong Buy | Strong Buy |
4/1/2024 | Cowen & Co. | Yaron Werber | Strong Buy | Strong Buy |
3/27/2024 | Not Identified | Not Identified | Hold | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.20 |
ABR (Last week) | 1.20 |
# of Recs in ABR | 5 |
Average Target Price | $6.75 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 83 of 252 |
Current Quarter EPS Est: | -0.14 |
NUVB FAQs
Nuvation Bio Inc. (NUVB) currently has an average brokerage recommendation (ABR) of 1.20 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 5 brokerage firms.
The average price target for Nuvation Bio Inc. (NUVB) is $6.75. The current on short-term price targets is based on 4 reports.
The forecasts for Nuvation Bio Inc. (NUVB) range from a low of $5 to a high of $10. The average price target represents a increase of $180.08 from the last closing price of $2.41.
The current UPSIDE for Nuvation Bio Inc. (NUVB) is 180.08%
Based on short-term price targets offered by four analysts, the average price target for Nuvation Bio Inc. comes to $6.75. The forecasts range from a low of $5.00 to a high of $10.00. The average price target represents an increase of 188.46% from the last closing price of $2.34.